Laboratory Tests for Patients with High ANA Titers

Initial Evaluation Based on ANA Pattern

The presence of both nucleolar and centromere patterns on ANA testing is strongly associated with limited cutaneous systemic sclerosis and requires targeted follow-up testing, including specific anti-centromere antibodies (CENP-A, B, C, F) and testing for systemic sclerosis-specific antibodies, according to the European League Against Rheumatism 1
The nucleolar pattern is associated with systemic sclerosis, Raynaud's phenomenon, inflammatory myopathies, and overlap syndromes, as stated by the American College of Rheumatology 1, 2
Testing for specific nucleolar antigens, including PM/Scl, U3-RNP, and To/Th, is recommended for patients with a nucleolar pattern, as suggested by the European League Against Rheumatism 1, 2, 3

The American College of Rheumatology recommends testing for anti-centromere antibodies (CENP-A, B, C, F) in patients with a centromere pattern 1
Testing for anti-fibrillarin (U3-RNP) is recommended for patients with a nucleolar pattern, according to the American College of Rheumatology 2
The European Association for the Study of the Liver recommends testing for anti-mitochondrial antibodies (AMA) to rule out primary biliary cirrhosis 4
Testing for anti-smooth muscle antibodies (SMA) and anti-liver/kidney microsomal antibody type 1 (anti-LKM-1) is recommended for autoimmune hepatitis, as stated by the European Association for the Study of the Liver 5

The American College of Rheumatology states that ANA titers should be reported with patterns and highest dilution showing reactivity, and that clinically significant positivity starts at 1:40 dilution in adults 6
The European League Against Rheumatism recommends that specific antibody testing should be performed regardless of ANA titer when clinical suspicion is high 2
The European Association for the Study of the Liver suggests that the laboratory should report any level of positivity from 1:10, with interpretation based on clinical context and patient age 5

The American College of Rheumatology recommends that HEp-2 cells are the preferred substrate for ANA detection as they better visualize nucleolar and centromere patterns 1
The European League Against Rheumatism states that false negatives can occur with automated methods, and that IIFA (indirect immunofluorescence assay) remains the reference standard 3